Rotavirus RRV gene 11 encodes two non-structural proteins, NSP5 and NSP6. NSP5 is a phosphorylated non-structural protein that binds single-and double-stranded RNA in a non-specific manner. Transient expression of this protein in uninfected cells has provided evidence for its participation in the formation of electron-dense cytoplasmic structures, known as viroplasms, which are thought to be key structures for the replication of the virus. NSP6 is a protein of unknown function that seems not to be essential for virus replication in cell culture. To study the function of NSP5 in the context of a viral infection, the expression of RRV gene 11 was silenced by RNA interference. Reduction in the synthesis of NSP5, as shown by immunoblot and immunofluorescence assays, correlated with a reduction in the number and size of viroplasms and with an altered intracellular distribution of other viroplasm-associated proteins. Silencing of gene 11 also resulted in a reduced synthesis of viral RNA(+) and double-stranded RNA and of all viral proteins, as well as in a decreased production of infectious virus. A similar phenotype was observed when the NSP5 coding gene of the lapine rotavirus strain Alabama was silenced. The fact that the NSP5 gene of rotavirus Alabama lacks the AUG initiator codon for a complete NSP6 protein, suggests that the described phenotype in gene 11-silenced cells is mostly due to the absence of NSP5. The data presented in this work suggest that NSP5 is a key protein during the replication cycle of rotaviruses.
INTRODUCTION
Rotaviruses, members of the family Reoviridae, have a genome composed of 11 segments of double-stranded RNA (dsRNA) that encodes six structural (VP1 to VP4, VP6 and VP7) and six non-structural (NSP1 to NSP6) proteins. The genome is enclosed in a capsid formed by three concentric layers of protein. The innermost layer, formed by VP2, contains the viral genome, the viral RNA polymerase VP1 and the capping enzyme VP3, which constitute the core of the virus. The addition of VP6 outside the VP2 layer produces double-layered particles (DLPs). The outermost layer, characteristic of triple-layered infectious particles (TLPs), is composed of two proteins, VP4 and VP7. The smooth external surface of the virus is formed by glycoprotein VP7, while 60 spike-like structures, formed by VP4, extend from the VP7 surface (Estes, 2001) .
During the process of infection, the infecting TLP is adsorbed, penetrates the plasma membrane and is uncoated, loosing the two outer layer proteins and yielding a transcriptionally active DLP. The viral polymerase VP1 then synthesizes the primary viral transcripts, which in addition to direct the synthesis of viral proteins, i.e. to function as mRNAs, are also believed to serve as RNA templates [RNA(+)] for the synthesis of the RNA-negative strands [RNA(2)] to form the genomic dsRNA (Estes, 2001; Patton et al., 2003) . Once a critical mass of viral proteins is synthesized, viral polypeptides NSP2, NSP5, NSP6, VP1, VP2, VP3 and VP6 accumulate in electron-dense cytoplasmic inclusions known as viroplasms (González et al., 2000; Mattion et al., 1991; Petrie et al., 1984) ; these are key structures in the replication of rotavirus, where the synthesis of dsRNA and assembly of progeny DLPs are thought to take place (Estes, 2001 ).
The synthesis of RNA(2) has been proposed to occur concurrently with the packaging of RNA(+) into core replication intermediate (RI) particles (formed by VP1, VP2, VP3, and the non-structural proteins NSP2 and NSP5) in a highly coordinated manner, such that packaging and replication of RNA(+) lead to the formation of cores containing one copy of each of the 11 dsRNA genome segments (Patton et al., 2003) . Assembly of VP6 onto core RIs is then believed to lead to the production of transcriptionally active, dsRNAcontaining DLPs (Estes, 2001 ). These particles are thought to initiate a second round of transcription, which results in an amplified second wave of viral protein synthesis and assembly of DLPs, as has been shown for reovirus (Nibert & Schiff, 2001) . Finally, the assembled DLPs bud through the membrane of the ER, acquiring during this process a transient membrane envelope, which is subsequently removed to yield mature infectious TLPs (Estes, 2001; Patton, 1995) . Although the mechanism through which the transient membrane envelope is lost is not known, it has been recently shown to depend on VP7 (Ló pez et al., 2005) .
Rotavirus gene 11 encodes two proteins, NSP5 and NSP6. NSP5 is an O-glycosylated phosphoprotein (Afrikanova et al., 1996; González & Burrone, 1991) present in several phosphorylated isoforms, which are thought to regulate their own phosphorylation (Afrikanova et al., 1996; Blackhall et al., 1998; Eichwald et al., 2004; Eichwald et al., 2002) . NSP5 has been shown to interact in a sequence independent fashion with dsRNA and single-stranded (ss) RNA (Vende et al., 2002) , and it has been suggested that its phosphorylation state influences the rate of translation versus replication of the viral RNA (Chnaiderman et al., 2002) . When co-expressed with NSP2, in the absence of other viral proteins, NSP5 forms viroplasm-like structures (Fabbretti et al., 1999) , and more recently it was shown that amino-terminal deletion mutants of this protein can form viroplasm-like structures in the absence of NSP2 (Mohan et al., 2003) . NSP5 has also been shown to have a strong affinity to VP2, to an extent that it can outcompete VP6 in VLPs (Berois et al., 2003) . Despite the extensive characterization of the biochemical properties of NSP5, and the description of its viroplasm-forming properties by transient expression in uninfected cells, the role and relevance of this protein in the context of virus replication has not been determined.
NSP6 is a 92 aa protein of unknown function, encoded in a +1 alternative open reading frame (ORF) of rotavirus gene 11 (Mattion et al., 1991) . The NSP5 gene of many rotavirus strains has an ORF that could potentially encode NSP6; however, its synthesis has only been demonstrated in a few rotavirus strains (Mattion et al., 1991; Torres-Vega et al., 2000) . In addition, the fact that some rotaviruses do not have this ORF suggests that NSP6 is not essential for virus replication (Mattion et al., 1991; Torres-Vega et al., 2000) .
RNA interference (RNAi) is a process triggered by dsRNA that specifically silences the expression of the gene which shares sequence identity with the triggering dsRNA. The recent implementation of the RNAi technology to efficiently silence gene expression in mammalian cells has opened a tremendous opportunity for a rapid advance in the characterization of gene function (Elbashir et al., 2001) . This technology has also proven to be extremely useful to study the function of genes from plant and animal viruses, including rotaviruses (Arias et al., 2004; Dector et al., 2002; Ló pez et al., 2005; Silvestri et al., 2004) .
To evaluate directly the role of NSP5 in the context of the replication of rotaviruses in infected cells, we silenced the expression of rotavirus RRV gene 11 by RNAi. We found that reduced amounts of NSP5 correlated with the inhibition of genomic dsRNA and viral protein synthesis, as well as with a marked reduction in the production of infectious viral progeny. These data indicate an essential role of NSP5 in the replication of rotaviruses, and give further insight into the function this protein plays in the virus replication cycle.
METHODS
Cells, viruses and antibodies. The monkey kidney epithelial cell line MA104 was grown in Eagle's minimal essential medium (MEM) supplemented with 10 % fetal bovine serum, and was used for all experiments carried out in this work. The rhesus rotavirus strain RRV (P5B,G3) and the human rotavirus strain Wa (P1A,G1) were obtained from Dr. H. B. Greenberg, Stanford University, Stanford, CA; the bovine rotavirus strain RF (P6,G6) was kindly provided by Dr. J. Cohen, CNRS-INRA, Gif-sur-Yvette, France; and the lapine strain Alabama (P[14],G3) was obtained from Dr. M. Conner, Baylor College of Medicine Houston, TX. All rotavirus strains were propagated in MA104 cells as described previously (Pando et al., 2002) . Monoclonal antibodies (mAbs) to VP2 (mAb 3A8), VP6 (mAb 255/ 60), NSP4 (mAb B4) and VP7 (mAb 60) were kindly provided by Dr. H. B. Greenberg. Rabbit polyclonal sera to NSP2 and NSP5 have been described previously (González et al., 2000) . Polyclonal antibodies to purified RRV TLPs were produced in rabbits as described previously (Ló pez et al., 2005) . Antibodies to vimentin were raised in rabbits by immunization with human recombinant vimentin produced in bacteria, expressed from a plasmid kindly provided by Dr. J. F. Hess, University of California, Davis, CA. Polyclonal antibodies to a fragment of RRV VP4 (aa 474-776) synthesized in, and purified from, bacteria as described previously (Zarate et al., 2003) , were produced in rabbits. Alexa-488-and -568-conjugated secondary antibodies were purchased from Molecular Probes (Eugene). Horseradish peroxidase-conjugated goat antirabbit polyclonal antibody was from Perkin Elmer Life Sciences and horseradish peroxidase-conjugated rabbit anti-mouse IgG was from Zymed.
Sequence and lipofection of small interfering RNAs (siRNAs). For this work two NSP5 siRNAs corresponding to nt 95-115 (siRNA NSP5-1 ) and 244-264 (siRNA NSP5-2 ) of rotavirus RRV gene 11 (Mohan & Atreya, 2001) were purchased from Dharmacon Research. siRNA NSP5-1 had the sequence 59-UCUAUUGGUAGGA-GUGAACTT-39 (sense), 59-GUUCACUCCUACCAAUAGATT-39 (antisense), while siRNA NSP5-2 had the sequence 59-GACAAAUG-CAGACGCUGGCTT-39 (sense), 59-GCCAGCGUCUGCAUUUGU-CTT-39 (antisense). Both NSP5 siRNAs silenced the expression of gene 11 with similar efficiency. As a negative control a previously reported lamin siRNA was used (Dector et al., 2002; Elbashir et al., 2001) . Confluent monolayers of MA104 cells in 48-or 96-well plates were lipofected with 100 or 50 ml, respectively, of a mixture containing 40 mg lipofectamine (Invitrogen) ml 21 and 600 pmol siRNAs ml 21 in MEM without serum. The transfection mixture was added to cells previously washed with MEM and incubated for 8 h at 37 uC. After this time the transfection mixture was removed, the cells were washed with MEM and kept in this medium without serum or antibiotics for 36 h at 37 uC, before being infected at an m.o.i. of 3.
Infection of cells and titration of viral progeny. Cell monolayers in 96-well plates were infected with an m.o.i. of 3 as described previously (Pando et al., 2002) , and then incubated for 14-16 h at 37 uC. At this time the cells were lysed by two freeze-thaw cycles, and the lysates were treated with 10 mg trypsin ml 21 for 30 min at 37 uC. The infectious titre of the viral preparations was obtained by an immunoperoxidase focus assay (Pando et al., 2002) .
Immunoblots. Cells were transfected with siRNAs and infected with individual rotavirus strains RRV, Wa, RF or Alabama as described above. At 12 h post-infection (p.i.) the cells were lysed with Laemmli sample buffer, the proteins separated by 14 % SDS-PAGE and transferred to Immobilon-NC (Millipore). The transferred proteins were incubated with a mixture of rabbit polyclonal antibodies to purified rotavirus RRV, NSP5 and vimentin, and the bound antibodies were developed by incubation with a peroxidase-labelled anti-rabbit antibody (Perkin-Elmer Life Sciences) and the Western Lightning system (Perkin-Elmer).
Radiolabelling of proteins and RNA. For protein labelling, cells grown in 48-well plates were transfected with siRNAs and infected with rotavirus RRV as described above. At the indicated times, the medium was replaced by MEM without methionine, supplemented with 50 mCi (1?85 MBq) Easy Tag Express 35 S-labelling mix (Dupont NEN) ml 21 and incubated for 30 min; after this period the cells were washed and lysed with Laemmli sample buffer. The relative concentration of protein in each sample was adjusted by eye inspection of Coomassie blue-stained gels, and the same amount of protein in each sample was resolved by 11 % SDS-PAGE. For RNA labelling, cells grown in 12-well plates were transfected with siRNAs and infected with rotavirus RRV as described above. After the virus adsorption period, actinomycin (5 mg ml
21
; Sigma) was added to the cells; 1 h later 50 mCi [ was added in phosphate-free MEM containing actinomycin, and the cells were further incubated for 10 h at 37 uC. At this time total RNA was extracted from the cells with Trizol (Invitrogen). ssRNA and dsRNA were resolved in denaturing 7 M urea polyacrylamide gels as described previously (Silvestri et al., 2004) . Radiolabelled RNAs were detected with a Molecular Dynamics PhosphorImager.
Analysis of genomic dsRNA. Genomic dsRNA was isolated from viral lysates and analysed by PAGE and silver staining as described previously (Herring et al., 1982) .
Immunofluorescence. MA104 cells were grown on coverslips and infected as described above. The cells were fixed 8 h p.i. with 2 % paraformaldehyde and permeabilized with 0?5 % Triton X-100 in 1 % BSA, as described previously (Dector et al., 2002) . The cells were then incubated with either rabbit polyclonal sera to NSP2, NSP5 or VP4, or with mAbs 3A8, 255/60, 60 or B4, followed by staining with goat anti-mouse IgG coupled to Alexa-568 or goat anti-rabbit IgG coupled to Alexa-488 (Molecular Probes). The slides were analysed with a Bio-Rad MRC-600 confocal microscope and CoMOS MPL-1000 software.
Real-time RT-PCR. The level of gene 10 RNA(+), which includes both gene 10 mRNA and the positive-strand RNA present in gene 10 dsRNA, was quantified by real-time RT-PCR. Briefly, MA104 cells grown in 12-well plates were transfected with siRNAs and infected with rotavirus RRV as described above. At the indicated times the cells were lysed with Trizol and total RNA was purified according to manufacturer's instructions. cDNA was synthesized from 0?1 to 1 ng of total RNA using primer 59-TCCTGGAA-TGGCGTATTTTC-39, which corresponds to nt 122-141 of RRV gene 10. The DNA was then amplified in the presence of a SybrGreen PCR master mix (Applied Biosystems) by addition of reverse primer 59-GAGCAATCTTCATGGTTGGAA-39 (nt 173-193 of RRV gene 10), using an ABI Prism 7000 detection system (Applied Biosystems). The results were normalized to the levels of GAPDH mRNA detected in each RNA sample (Winer et al., 1999) .
RESULTS

Silencing the expression of rotavirus gene 11 reduces viral progeny and viral protein synthesis
To study the relevance of gene 11 products in the context of a viral infection, two siRNAs (siRNA NSP5-1 and siRNA ) corresponding to the sequence of rotavirus RRV gene 11 (Mohan & Atreya, 2001) were synthesized and transfected into MA104 cells. The cell monolayers were infected 36 h post-transfection with rotavirus strain RRV at an m.o.i. of 3, and 14-16 h later the titre of viral progeny produced was determined by a focus-forming assay. The two siRNAs tested interfered with the replication of RRV with similar efficiency; the infectious viral progeny produced in cells transfected with either siRNA was reduced by 70-80 % as compared with the yield of RRV obtained from cells transfected with an irrelevant, control siRNA (Table 1) . To confirm that the synthesis of NSP5 was being specifically blocked by the siRNAs, cells transfected with siRNA were infected with rotavirus RRV, and 12 h p.i. the viral proteins were analysed by immunoblotting, using a mixture of rabbit polyclonal sera to NSP5, to purified RRV TLPs, and to vimentin as an internal loading control (Fig. 1a) . As expected, the amount of NSP5 was drastically reduced, however, a reduction in the level of the structural viral proteins VP4, VP6 and VP7 was also observed, while the level of vimentin was not altered. The general reduction in the synthesis of both structural and non-structural viral proteins was confirmed by SDS-PAGE analysis of viral proteins metabolically labelled with an 35 S-labelling mix, produced in an infection made in the presence or absence of the siRNA to NSP5 (Fig. 1b) .
It has been reported that siRNAs can activate the interferon system, causing a non-specific inhibition of cell protein synthesis (Kim et al., 2004; Persengiev et al., 2004; Sledz et al., 2003) . To evaluate if the general inhibition of the synthesis of viral protein induced by siRNA NSP5-1 was specific, we analysed the effect of this siRNA on the production of viral progeny and viral protein synthesis of the human rotavirus strain Wa and the bovine rotavirus strain RF. The sequence of siRNA NSP5-1 corresponding to RRV gene 11 is identical in rotavirus RF, but differs in rotavirus Wa gene 11 by 2 nt (at positions 14 and 15 of the sense sequence). If the siRNA is inducing a non-specific effect, the production of the viral progeny of all three viruses should be affected. As shown in Table 1, siRNA NSP5-1 did not affect the production of rotavirus Wa progeny, but had a strong effect in the case of RF, similar to that observed for RRV. Also, immunoblot analysis of the viral proteins synthesized in the presence of siRNA showed that this siRNA, but not a control siRNA, reduced the accumulation of NSP5 and other viral proteins in cells infected with rotavirus RF, but not in cells infected with rotavirus strain Wa (Fig. 1c) . These results indicate that the reduction in viral progeny and viral protein expression is a consequence of the specific inhibition of the expression of gene 11 induced by siRNA NSP5-1 .
Interference of rotavirus gene 11 expression reduces the general synthesis of viral mRNAs and genomic dsRNA
To analyse the effect of silencing the expression of gene 11 on the synthesis of viral messenger and genomic RNA, siRNA NSP5-1 -transfected cells were infected with RRV, the cells were labelled with [ 32 P]orthophosphate for 10 h, starting 2 h p.i., followed by the extraction of total RNA from the cell lysates and analysis by PAGE, using the conditions described by Silvestri et al. (2004) that allow the detection of viral mRNAs and most segments of dsRNA (Fig. 2a) . A reduction in the accumulation of all viral transcripts and dsRNA was observed in the presence of siRNA NSP5-1 as compared with cells transfected with an irrelevant siRNA. The amount of viral dsRNA synthesized was also analysed by PAGE and silver staining of unlabelled dsRNA extracted at 12 h p.i. Similar to what was observed for 32 P-labelled RNA, the amount of dsRNA was also found to be diminished in cells transfected with siRNA NSP5-1 , as compared with cells transfected with a control siRNA or with an siRNA to RRV VP4 (Dector et al., 2002) (Fig. 2b) .
Interfering with the expression of NSP5 in a rotavirus strain lacking a complete ORF for NSP6
Gene 11 of some rotavirus strains does not contain the complete NSP6 ORF present in most strains, which potentially encodes a protein of 92 aa. In some cases, e.g. rotavirus strain OSU, the NSP6 ORF encodes a 51 aa protein, while in others, like rotavirus strains Alabama or Mc323, there is no initiator AUG at the beginning of the potential second ORF, but it is not known whether a shorter NSP6, starting from a downstream AUG could be synthesized (Fig. 3b) . To test if NSP6 contributes to the phenotype observed when gene 11 is silenced, we characterized the yield of viral progeny and viral protein synthesis in cells infected with the lapine rotavirus strain Alabama in the presence of an NSP5 siRNA. Rotavirus strain Alabama was chosen, since rotavirus OSU has already been tested (Campagna et al., 2003) , and rotavirus strain Mc323 was not available. Since buffer. The labelled proteins were resolved by SDS-PAGE and detected by autoradiography. (c) Immunoblot analysis of rotavirus strains RF and Wa carried out as described in (a). In all cases the amount of loaded protein was previously adjusted by eye inspection of Coomassie blue-stained gels; the amount of vimentin was used as an internal control to verify that the loaded protein was comparable in each case. The siRNAs used in these assays were siRNA NSP5-1 (NSP5) or an irrelevant siRNA (Ctrl).
siRNA NSP5-1 has two mismatches with the target sequence of Alabama gene 11, we used siRNA , whose target sequence is identical in rotaviruses RRV and Alabama. The interference of gene 11 expression in Alabama reduced the production of viral progeny (Table 1 ) and the synthesis of viral protein (Fig. 3a) , although the inhibition of viral progeny was somewhat lower (50 %) as compared with that achieved with RRV (80 %).
Intracellular distribution of several viral proteins is altered in gene 11-silenced cells
The level of reduction achieved in the titre of RRV viral progeny and viral protein synthesis in cells transfected with siRNA NSP5-1 is consistent with the efficiency of transfection achieved with this siRNA, of about 70 % (data not shown and Dector et al., 2002) . These results suggest that the viral proteins and infectious virus produced in the cells successfully transfected with siRNA NSP5-1 is none or very low. Thus, to determine the effect of silencing rotavirus gene 11 on the synthesis of NSP5 and other viral proteins at the individual cell level, siRNA NSP5-1 -transfected cells were infected with RRV at an m.o.i. of 3, and examined by immunofluorescence with mono-specific sera to different proteins. NSP5 was still detectable and localized to viroplasms in most cells, although the number and size of viroplasms was reduced as compared with cells transfected with an siRNA control (Fig. 4, panel NSP5 ). These results confirm the reduction of the synthesis of NSP5 observed by immunoblot and indicate that silencing of gene 11 expression by siRNA NSP5-1 , although efficient, does not completely prevent the synthesis of NSP5.
The immunofluorescence analysis of viral proteins other than NSP5 in cells infected in the presence of siRNA showed, as expected, a reduced signal, but also an altered intracellular distribution (Fig. 4) . Most of NSP2 and VP2 were found to co-localize with NSP5 in viroplasms, as in control cells, but a fraction of these proteins was also found dispersed in the cytoplasm. In the case of VP4, the ring-like or semicircular structures observed in control cells, which have been reported to be closely associated to viroplasms (González et al., 2000) , disappeared leaving a finely punctated pattern. The filamentous distribution of VP4, which has been suggested to result from the association . The viral mRNAs and dsRNA genes were separated by PAGE under conditions as described in Methods and detected by a PhosphorImager. The genomic dsRNA segments (indicated at left) and the viral mRNAs (indicated at right) were identified by running 32 P-labelled viral dsRNA as a marker (not shown). (b) Total dsRNA was purified from cell lysates of RRV-infected cells that had been previously transfected with either an siRNA control (Ctrl), siRNA NSP5-1 (NSP5) or an siRNA to rotavirus RRV VP4 gene (VP4). The extracted dsRNA segments were separated by PAGE and detected by silver staining. The position of the genes 4 and 11 encoding VP4 and NSP5, respectively, is indicated. The same volume fraction from the total volume collected for each sample was loaded in the gel. ). Similar to VP4, the distribution of NSP4 also changed from a viroplasm-associated ring-like appearance (González et al., 2000) to a more dispersed finely punctated pattern. VP7 also changed its distribution from a predominant ring-like pattern associated with viroplasms (González et al., 2000) in control cells, to a more diffuse perinuclear signal. The more drastic change observed, however, was the distribution of VP6, where most of the protein shifted from a viroplasm location to a fibrous array in the cytoplasm. The fibres of VP6 did not co-localize with tubulin, actin or vimentin (data not shown).
Silencing the expression of gene 11 blocks late viral transcription and protein synthesis
The reduced synthesis of viral protein, mRNA, dsRNA and progeny particles described above, suggests that the inhibition of gene 11 expression blocks the replication of the viral genome and the putative second round of transcription. If this is correct, one would expect that the primary synthesis of viral mRNA and protein that takes place early after infection would not be affected (except for NSP5), but the inhibition would be evident rather late in the replication cycle, when the secondary round of transcription and translation occurs. To test this hypothesis, MA104 cells were infected with rotavirus RRV at an m.o.i. of 3, and the infected cells were pulse-labelled every hour for 30 min with an 35 S-labelling mix, starting 1 h after infection (Fig. 5a ). The level of NSP5 was detected by immunoblot using the same samples shown in Fig. 5(a) (Fig. 5b) . The inhibition of the synthesis of NSP5 was already evident at 2 h p.i., a time point at which this protein was first detected in control cells. In contrast, the synthesis of the rest of the viral proteins was similar in the NSP5 siRNA-and control siRNA-transfected cells until 3 h p.i., while the inhibition of their synthesis started to be noticed at 4 h p.i. and was maximal at 6-8 h p.i.
We also determined the accumulation of gene 10 RNA(+) Fig. 4 . The distribution of viral proteins is altered in cells transfected with the NSP5 siRNA. The synthesis and intracellular distribution of NSP5 and other viral proteins in rotavirus RRV-infected cells in the presence of siRNA NSP5-1 (NSP5) or an unrelated siRNA (Control), as indicated, was determined. The cells were fixed at 8 h p.i. and stained with either mAbs to VP2 (3A8), NSP4 (B4), VP7 (60) or VP6 (255/60), or with polyclonal antibodies to NSP2, NSP5 or VP4 as primary antibodies, as indicated inside each image, followed by incubation with goat anti-mouse IgG coupled to Alexa-568 or goat anti-rabbit IgG coupled to Alexa-488, as secondary antibodies.
at different times p.i. by semi-quantitative RT-PCR (Fig. 5c) . Gene 10 was selected as marker of the general synthesis of viral RNA, since the RT-PCR conditions for its measurement were already set up in the laboratory (C. Ayala-Breton and others, unpublished data) . Similar to what was observed for protein synthesis, at 3 h p.i. the gene 10 RNA(+) levels were similar in cells infected in the presence of the siRNA NSP5-1 , as compared to control cells, while a clear difference between these two conditions was found at 6 h p.i.
DISCUSSION
It has been suggested that rotavirus non-structural protein NSP5 is involved at several stages during the replication of the viral genome, including the formation of viroplasms, the transport of viral RNAs (+) to these inclusions, and the preparation of these RNAs for packaging and replication (Patton et al., 2003) . NSP5 has also been implicated in the regulation of the translation of viral mRNAs (Chnaiderman et al., 2002) and, given its capacity for binding dsRNA, in blocking the interferon-induced RNA-dependent activation of protein kinase PKR (Vende et al., 2002) . However, with exception of its ability to form viroplasm-like structures when transiently expressed in uninfected cells (Fabbretti et al., 1999; Mohan et al., 2003) , there is no direct evidence either in vivo or in vitro for its suggested functions. In this work, we studied the role of NSP5 in the context of a viral infection, using RNAi technology to suppress gene expression in mammalian cells.
Although the RNAi response induced by siRNA most probably inhibits the synthesis of both NSP5 and NSP6, the block in virus replication, as well as the reduced synthesis of viral components observed in this work is most likely the result of the impaired levels of synthesis of NSP5. This conclusion is supported by the following observations: (i) an ORF encoding a full-length NSP6 is not present in gene 11 of some group A rotaviruses (strains Mc323, Alabama, 512-C and OSU -GenBank accession numbers U54772, J04361, AB008662 and X15519, respectively) and is missing in all group C rotavirus strains (Torres-Vega et al., 2000) , suggesting that NSP6 is not essential for the replication of the virus; (ii) the expression of intracellular antibodies to NSP5 caused a phenotype similar to that described in this work (Vascotto et al., 2004) ; (iii) silencing the expression of gene 11 of porcine rotavirus strain OSU, which encodes a truncated NSP6 ORF, resulted in the general reduction of viral protein synthesis and inhibition of rotavirus replication (Campagna et al., 2003.) ; and (iv) the inhibition effect of siRNA NSP5-2 on the replication and protein synthesis of rotavirus Alabama described in this work was similar to that observed for rotavirus RRV. The gene 11 of Alabama strain does not have an AUG codon at the beginning of the ORF that would code for a 92 aa NSP6 protein, like most other rotavirus strains. It rather has an in-phase downstream AUG that could potentially code for a protein of 79 aa. If this protein is indeed synthesized and if it is functional, it would imply that the 79 carboxy-terminal amino acids of NSP6 are enough to sustain its function. Furthermore, as mentioned above, rotavirus OSU gene 11 produces a 51 aa truncated version of NSP6, and its silencing also causes a reduction of viral protein and genomic dsRNA synthesis (Campagna et al., 2003) . Although it is not possible to discard a central role of NSP6 in rotavirus replication, these observations suggest that most probably NSP6 plays a regulatory role of the NSP5 activity, as previously suggested (Torres-Vega et al., 2000) , a role that might have been substituted somehow in the strains that lack the full-length NSP6. or NSP5-1 (closed bars) siRNAs, as indicated, were infected with rotavirus RRV, and at the indicated times (T0, T3, T6, and T9 at 0, 3, 6 and 9 h p.i., respectively) total RNA was extracted with Trizol, and the levels of gene 10 RNA(+) were determined by real-time RT-PCR. The results are expressed as foldincrease over the levels detected at time zero of infection (immediately after the end of the virus adsorption period). The arithmetic mean, with one standard deviation, of two independent experiments is shown.
Gene 11-silenced cells showed fewer and smaller viroplasms than cells transfected with the control siRNA, as well as a partial delocalization of viroplasmic proteins VP2, NSP2 and VP6 (Fig. 4) , strongly suggesting that NSP5 is essential to nucleate the formation of these cytoplasmic inclusions (Fabbretti et al., 1999) . It would appear that in the absence of a regular amount of NSP5 the number and size of viroplasms decreases, causing that only a fraction of viroplasmic proteins anchors to these structures, while the 'excess' of these proteins redistributes in the cytoplasm. In contrast to NSP2 and VP2, whose 'excess' became homogeneously distributed in the cytoplasm, VP6 showed a dramatic redistribution into fibrous structures that appear to extend to the periphery of the cell. The reason for this fibrous pattern of VP6 is not clear, since the VP6 fibres did not co-localize with vimentin, actin or tubulin, and had variable thickness (data not shown). The distribution of VP6 into fibres was also observed when the expression of NSP4 was silenced (Ló pez et al., 2005) ; in that case, the amounts of NSP2 and NSP5 were also reduced, and the mean size of the viroplasms was also smaller, suggesting that the distribution of VP6 is sensitive to the concentration of proteins that accumulate in viroplasms and that treatments that alter this concentration cause VP6 to redistribute as fibres. The reason for this delocalization is not clear, but NSP5 might have an unrecognized role in the recruitment of viral proteins to viroplasms. Direct interaction with NSP5 has been demonstrated for NSP6, NSP2, VP1 and VP2, and changes in the distribution of VP2 were observed when NSP5 was coexpressed in insect cells (Berois et al., 2003) . In the case of VP6, there are no reports describing a direct interaction with NSP5 and, in fact, NSP5 has been reported to dislodge VP6 from virus-like particles formed by VP2 and VP6 (Berois et al., 2003) . Recently, it was shown that the inhibition of NSP2 expression also inhibits viroplasm formation, genome replication, virus assembly, and the synthesis of the viral proteins (Silvestri et al., 2004) ; however, the intracellular distribution of the viral proteins in NSP2-deficient cells was not characterized. VP4, VP7 and NSP4, which are not integral viroplasmic proteins but are closely associated to these structures (González et al., 2000) , were also delocalized in gene 11-silenced cells, probably as an indirect effect of the reduced size and number of viroplasms.
The data presented in this work support the existence of a second round of transcription driven by de novo synthesized DLPs (Fig. 5) . The impaired number and size of viroplasms produced in gene 11-silenced cells probably causes a decreased production of DLPs that results in a deficient secondary synthesis of viral mRNA, with the consequent reduction of: (i) the synthesis of viral proteins and genomic dsRNA; (ii) the formation of 'healthy' viroplasms; and (iii) the assembly of DLPs, and eventually infectious TLPs. As predicted by this model, early after virus infection (3 h or earlier) of siRNA NSP5 -transfected cells only the accumulation of NSP5 (the siRNA target) is clearly affected (Fig. 5a) , while the synthesis of other viral proteins and of RNA(+), as judged from the levels of gene 10 RNA, are not affected, indicating that at the beginning of infection the RNA(+) is mostly produced by the parental infecting DLP. At later times (4 h p.i. and later) all viral proteins and viral RNA(+) start to be inefficiently produced because, in the absence of NSP5, viroplasms are scarce, and a limited amount of progeny DLPs are assembled, with the consequent reduction in viral protein and RNA(+), and an inhibition of the production of progeny infectious virus. Experiments are currently being carried out in our laboratory to characterize in detail the timing of transcription and replication of the virus genome during the rotavirus infection cycle, and the effect on this timing of silencing the expression of various structural and non-structural viral proteins.
